Interleukin-12 genetic administration suppressed metastatic liver tumor unsusceptible to CTL

Biochemical and Biophysical Research Communications

Volumn 314, Issue 4, 2004, Pages 1072-1079

  Itokawa, Yoshiki ^a   Mazda, Osam ^a   Ueda, Yuji ^a   Kishida, Tsunao ^a   Asada, Hidetsugu ^a   Cui, Feng De ^a   Fuji, Nobuaki ^a   Fujiwara, Hitoshi ^a   Shin Ya, Masaharu ^a   Yasutomi, Kakei ^a   Imanishi, Jiro ^a   Yamagishi, Hisakazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Cytotoxic T lymphocytes; Epstein Barr virus based plasmid vector; Gene therapy; Hydrodynamics based transfection; Interleukin 12; Liver metastasis; Peritoneal carcinomatosis; Tumor

Indexed keywords

PLASMID VECTOR; RECOMBINANT INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MODEL; CANCER PREVENTION; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOMATOSIS; CELL BASED GENE THERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DNA TRANSFECTION; FEMALE; INOCULATION; LIVER METASTASIS; LONGEVITY; MOUSE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; SURVIVAL TIME;

ANIMALIA; HUMAN HERPESVIRUS 4; MURINAE;

EID: 9144262941     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.12.200     Document Type: Article

References (30)

1. Colombo M.P., Trinchieri G. Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev. 13:2002;155-168.
2. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nature Rev. Immunol. 3:2003;133-146.
3. Rodolfo M., Zilocchi C., Melani C., Cappetti B., Arioli I., Parmiani G., Colombo M.P. Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines. J. Immunol. 157:1996;5536-5542.
4. Asada H., Kishida T., Hirai H., Satoh E., Ohashi S., Takeuchi M., Kubo T., Kita M., Iwakura Y., Imanishi J., Mazda O. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin-12 (IL-12) and IL-18 by means of the EBV/lipoplex. Mol. Ther. 5:2002;609-616.
5. Garrido F., Ruiz-Cabello F. MHC expression on human tumors - its relevance for local tumor growth and metastasis. Semin. Cancer Biol. 2:1991;3-10.
6. O. Mazda, W.T. Germeraad, Tumor immunity and immuno-gene therapy of malignancies, in Frontiers in immuno-gene therapy, in: Mazda, O., (Ed.), Research Signpost, Trivandrum, in press.
7. Hart I.R., Talmadge J.E., Fidler I.J. Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ-specific growth. Cancer Res. 41:1981;1281-1287.
8. Fuji N., Fujiwara H., Ueda Y., Taniguchi F., Yoshimura T., Oka T., Yamagishi H. Augmentation of local antitumor immunity in the liver by tumor vaccine modified to secrete murine interleukin 12. Gene Ther. 6:1999;1120-1127.
9. Kishida T., Asada H., Satoh E., Tanaka S., Shinya M., Hirai H., Iwai M., Tahara H., Imanishi J., Mazda O. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice. Gene Ther. 8:2001;1234-1240.
10. Kishida T., Asada H., Itokawa Y., Yasutomi K., Shin-Ya M., Gojo S., Cui F.D., Ueda Y., Yamagishi H., Imanishi J., Mazda O. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice. Mol. Ther. 8:2003;738-745.
11. Osaki T., Hashimoto W., Gambotto A., Okamura H., Robbins P.D., Kurimoto M., Lotze M.T., Tahara H. Potent antitumor effects mediated by local expression of the mature form of the interferon-gamma inducing factor, interleukin-18 (IL-18). Gene Ther. 6:1999;808-815.
12. Yates J.L., Warren N., Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature. 313:1985;812-815.
13. Liu F., Song Y., Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6:1999;1258-1266.
14. Zhang G., Budker V., Wolff J.A. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 10:1999;1735-1737.
15. Cui F.D., Kishida T., Ohashi S., Asada H., Yasutomi K., Satoh E., Kubo T., Fushiki S., Imanishi J., Mazda O. Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors. Gene Ther. 8:2001;1508-1513.
16. Mazda O. Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors. Curr. Gene Ther. 2:2002;379-392.
17. Portielje J.E., Gratama J.W., van Ojik H.H., Stoter G., Kruit W.H. IL-12: a promising adjuvant for cancer vaccination. Cancer Immunol. Immunother. 52:2003;133-144.
18. Sun Y., Jurgovsky K., Moller P., Alijagic S., Dorbic T., Georgieva J., Wittig B., Schadendorf D. Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study. Gene Ther. 5:1998;481-490.
19. Voest E.E., Kenyon B.M., O'Reilly M.S., Truitt G., D'Amato R.J., Folkman J. Inhibition of angiogenesis in vivo by interleukin 12. J. Natl. Cancer Inst. 87:1995;581-586.
20. Duda D.G., Sunamura M., Lozonschi L., Kodama T., Egawa S., Matsumoto G., Shimamura H., Shibuya K., Takeda K., Matsuno S. Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12. Cancer Res. 60:2000;1111-1116.
21. Tomiyasu K., Satoh E., Oda Y., Nishizaki K., Kondo M., Imanishi J., Mazda O. Gene transfer in vitro and in vivo with Epstein-Barr virus-based episomal vector results in markedly high transient expression in rodent cells. Biochem. Biophys. Res. Commun. 253:1998;733-738.
22. Lui V.W., He Y., Falo L., Huang L. Systemic administration of naked DNA encoding interleukin 12 for the treatment of human papillomavirus DNA-positive tumor. Hum. Gene Ther. 13:2002;177-185.
23. Wang Z., Qiu S.J., Ye S.L., Tang Z.Y., Xiao X. Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma. Cancer Gene. Ther. 8:2001;751-758.
24. Budker V., Budker T., Zhang G., Subbotin V., Loomis A., Wolff J.A. Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process. J. Gene Med. 2:2000;76-88.
25. Kobayashi N., Kuramoto T., Yamaoka K., Hashida M., Takakura Y. Hepatic uptake and gene expression mechanisms following intravenous administration of plasmid DNA by conventional and hydrodynamics-based procedures. J. Pharmacol. Exp. Ther. 297:2001;853-860.
26. Zhang G., Song Y.K., Liu D. Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure. Gene Ther. 7:2000;1344-1349.
27. Yang J., Chen S., Huang L., Michalopoulos G.K., Liu Y. Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth. Hepatology. 33:2001;848-859.
28. Eastman S.J., Baskin K.M., Hodges B.L., Chu Q., Gates A., Dreusicke R., Anderson S., Scheule R.K. Development of catheter-based procedures for transducing the isolated rabbit liver with plasmid DNA. Hum. Gene Ther. 13:2002;2065-2077.
29. Fujimoto J., Kanemura H., Takeuchi M., Horiguchi K., Ueki T., Sawa Y., Morishita R., Nakamura T., Kaneda Y. Hepatocyte growth factor gene therapy of liver cirrhosis by naked plasmid DNA transfer into liver. Mol. Ther. 1:2000;s22-s22.
30. Zhang G., Budker V., Williams P., Subbotin V., Wolff J.A. Efficient expression of naked DNA delivered intraarterially to limb muscles of nonhuman primates. Hum. Gene Ther. 12:2001;427-438.